Fatemeh Sheikhbahaei

Fatemeh Sheikhbahaei

Auto-generated profile, based on publicly available information

Fatemeh Sheikhbahaei

Department of Anatomy, Afzalipour School of Medicine, Kerman University of Medical Sciences, P. O. Box 76169 13555, Kerman, Iran.

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2026 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
HOHamideh Taheri Olyayie
Hamideh Taheri Olyayie
SNSeyed Noureddin Nematollahi‑Mahani
Seyed Noureddin Nematollahi‑Mahani
SJSaeideh Jafarinejad-Farsangi
Saeideh Jafarinejad-Farsangi
FSFatemeh Sheikhbahaei
Fatemeh Sheikhbahaei
MMMitra Mehrabani
Mitra Mehrabani
HBHamideh Bashiri
Hamideh Bashiri



3 November 2026
Verified
Book Chapter
Closed access
Tahmineh MokhtariTahmineh Mokhtari
Tahmineh Mokhtari
AMAsma Momeni
Asma Momeni
FSFatemeh Sheikhbahaei
Fatemeh Sheikhbahaei
ADAshkan Delavari
Ashkan Delavari
CKChangbin Ke
Changbin Ke
Major depressive disorder (MDD) pathophysiology extends beyond traditional monoaminergic mechanisms to include neuroinflammation, oxidative stress, mitochondrial dysfunction, and impaired neuroplasticity. This chapter comprehensively reviews emerging synthetic inhibitors targeting these non-monoaminergic pathways. Key therapeutic classes include NLRP3 inflammasome inhibitors, TNF-α antagonists, soluble epoxide hydrolase (sEH) inhibitors, NADPH oxidase (NOX) inhibitors, PARP inhibitors, and modulators of glycogen synthase kinase-3 (GSK-3) and Rho-associated protein kinase (ROCK). Preclinical evidence demonstrates robust efficacy in reversing depression-like behaviors and restoring synaptic plasticity. While several candidates show favorable pharmacokinetic profiles, clinical translation remains limited, necessitating optimized CNS penetration, biomarker-driven trials, and personalized treatment approaches for treatment-resistant depression.